Intuitive Surgical, Inc. (ISRG) shares
Intuitive Surgical, Inc. (ISRG) shares rallied 9.9% within the final buying and selling session to shut at $891.38. This transfer could be attributable to notable quantity with a better variety of shares being traded than in a typical session. This compares to the inventory’s 13.5% achieve over the previous 4 weeks.
Intuitive Surgical recorded strong value appreciation courtesy of its encouraging first-quarter 2021 outcomes, with reported earnings and revenues surpassing the Zacks Consensus Estimate by 34.9% and 16.2%, respectively. Substantial development (16%) in da Vinci process quantity and sturdy efficiency throughout all segments contributed to Intuitive Surgical’s robust first quarter efficiency.
Worth and Consensus
This firm is anticipated to put up quarterly earnings of $2.85 per share in its upcoming report, which represents a year-over-year change of +156.8%. Revenues are anticipated to be $1.15 billion, up 34.4% from the year-ago quarter.
Earnings and income development expectations actually give a superb sense of the potential power in a inventory, however empirical analysis reveals that developments in earnings estimate revisions are strongly correlated with near-term inventory value actions.
For Intuitive Surgical, Inc., the consensus EPS estimate for the quarter has been revised marginally larger during the last 30 days to the present degree. And a optimistic pattern in earnings estimate revision normally interprets into value appreciation. So, be sure that to keep watch over ISRG going ahead to see if this latest leap can flip into extra power down the highway.
The inventory at the moment carries a Zacks Rank 2 (Purchase). You’ll be able to see the whole checklist of right this moment’s Zacks Rank #1 (Sturdy Purchase) shares right here >>>>
Need the newest suggestions from Zacks Funding Analysis? In the present day, you’ll be able to obtain 7 Finest Shares for the Subsequent 30 Days. Click on to get this free report
Intuitive Surgical, Inc. (ISRG): Free Inventory Evaluation Report
To learn this text on Zacks.com click on right here.
Zacks Funding Analysis
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.